Rapty Sarker

408 total citations
17 papers, 154 citations indexed

About

Rapty Sarker is a scholar working on Infectious Diseases, Clinical Psychology and Experimental and Cognitive Psychology. According to data from OpenAlex, Rapty Sarker has authored 17 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Clinical Psychology and 4 papers in Experimental and Cognitive Psychology. Recurrent topics in Rapty Sarker's work include COVID-19 and Mental Health (4 papers), COVID-19 epidemiological studies (4 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). Rapty Sarker is often cited by papers focused on COVID-19 and Mental Health (4 papers), COVID-19 epidemiological studies (4 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers). Rapty Sarker collaborates with scholars based in Bangladesh. Rapty Sarker's co-authors include Md. Rabiul Islam, A. S. M. Roknuzzaman, Md. Jamal Hossain, Mohammad Shahriar, Eva Rahman Kabir, Md. Aminul Haque, M. M. A. Shalahuddin Qusar, Mohiuddin Ahmed Bhuiyan, Sardar Mohammad Ashraful Islam and Sheikh Zahir Raihan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Rapty Sarker

17 papers receiving 146 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rapty Sarker Bangladesh 8 67 31 28 23 22 17 154
A. S. M. Roknuzzaman Bangladesh 9 92 1.4× 43 1.4× 36 1.3× 33 1.4× 34 1.5× 24 207
Henry Kyobe Bosa Uganda 6 77 1.1× 63 2.0× 9 0.3× 22 1.0× 11 0.5× 18 109
Ami Fukunaga Japan 10 51 0.8× 52 1.7× 21 0.8× 3 0.1× 31 1.4× 45 197
Mosharop Hossian Bangladesh 7 45 0.7× 10 0.3× 49 1.8× 24 1.0× 24 1.1× 19 132
Isobel Ward United Kingdom 6 103 1.5× 9 0.3× 25 0.9× 25 1.1× 29 1.3× 14 172
Sarah Simmons United States 6 150 2.2× 18 0.6× 70 2.5× 31 1.3× 4 0.2× 12 258
Sami Abdeen Qatar 8 42 0.6× 13 0.4× 8 0.3× 19 0.8× 48 2.2× 18 147
Susana Rojas United States 5 112 1.7× 6 0.2× 26 0.9× 35 1.5× 22 1.0× 9 164
Susy Rojas United States 5 81 1.2× 6 0.2× 13 0.5× 25 1.1× 19 0.9× 5 124
Valerie Tulier-Laiwa United States 5 81 1.2× 6 0.2× 13 0.5× 25 1.1× 19 0.9× 5 124

Countries citing papers authored by Rapty Sarker

Since Specialization
Citations

This map shows the geographic impact of Rapty Sarker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rapty Sarker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rapty Sarker more than expected).

Fields of papers citing papers by Rapty Sarker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rapty Sarker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rapty Sarker. The network helps show where Rapty Sarker may publish in the future.

Co-authorship network of co-authors of Rapty Sarker

This figure shows the co-authorship network connecting the top 25 collaborators of Rapty Sarker. A scholar is included among the top collaborators of Rapty Sarker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rapty Sarker. Rapty Sarker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sarker, Rapty, et al.. (2024). A perspective on the worst ever dengue outbreak 2023 in Bangladesh: What makes this old enemy so deadly, and how can we combat it?. Health Science Reports. 7(5). e2077–e2077. 5 indexed citations
2.
Roknuzzaman, A. S. M., et al.. (2024). Altered serum interleukin-17A and interleukin-23A levels may be associated with the pathophysiology and development of generalized anxiety disorder. Scientific Reports. 14(1). 15097–15097. 5 indexed citations
3.
Sarker, Rapty, et al.. (2024). Altered eotaxin-1 and interleukin-34 levels in obsessive-compulsive disorder: a case-control observational study in Bangladesh. Osong Public Health and Research Perspectives. 16(1). 72–80. 1 indexed citations
4.
Sarker, Rapty, A. S. M. Roknuzzaman, Mohiuddin Ahmed Bhuiyan, & Md. Rabiul Islam. (2024). The upsurge of respiratory illnesses or pneumonia among children in Northern China: why is it hitting in China and is there any possibility to spread overseas?. International Journal of Surgery Open. 62(1). 72–75. 1 indexed citations
5.
Roknuzzaman, A. S. M., Rapty Sarker, Ahasanul Hasan, et al.. (2024). Exploring the role of interleukin-1β and interleukin-6 in the pathophysiology of obsessive-compulsive disorder. PLoS ONE. 19(6). e0306125–e0306125. 2 indexed citations
6.
Roknuzzaman, A. S. M., Rapty Sarker, Mamun M. Or-Rashid, et al.. (2024). Association of interleukin-2 and interleukin-10 with the pathophysiology and development of generalized anxiety disorder: a case-control study. BMC Psychiatry. 24(1). 462–462. 5 indexed citations
7.
Roknuzzaman, A. S. M., et al.. (2024). Exploring the association between online gaming addiction and academic performance among the school‐going adolescents in Bangladesh: A cross‐sectional study. Health Science Reports. 7(9). e70043–e70043. 3 indexed citations
8.
Sarker, Rapty, A. S. M. Roknuzzaman, Md. Aminul Haque, Md. Rabiul Islam, & Eva Rahman Kabir. (2024). Upsurge of dengue outbreaks in several WHO regions: Public awareness, vector control activities, and international collaborations are key to prevent spread. Health Science Reports. 7(4). e2034–e2034. 22 indexed citations
9.
Roknuzzaman, A. S. M., et al.. (2024). The WHO has Declared COVID-19 is No Longer a Pandemic-Level Threat: A Perspective Evaluating Potential Public Health Impacts. SHILAP Revista de lepidopterología. 17. 2632010X241228053–2632010X241228053. 9 indexed citations
10.
Sarker, Rapty, et al.. (2023). The WHO has declared the end of pandemic phase of COVID‐19: Way to come back in the normal life. Health Science Reports. 6(9). e1544–e1544. 41 indexed citations
11.
Sarker, Rapty, et al.. (2023). Altered serum TNF-α and MCP-4 levels are associated with the pathophysiology of major depressive disorder: A case-control study results. PLoS ONE. 18(11). e0294288–e0294288. 7 indexed citations
12.
Sarker, Rapty, M. M. A. Shalahuddin Qusar, Sardar Mohammad Ashraful Islam, Mohiuddin Ahmed Bhuiyan, & Md. Rabiul Islam. (2023). Association of granulocyte macrophage colony-stimulating factor and interleukin-17 levels with obsessive–compulsive disorder: a case–control study findings. Scientific Reports. 13(1). 18976–18976. 7 indexed citations
13.
Roknuzzaman, A. S. M., et al.. (2023). COVID‐19 vaccination success in Bangladesh: Key strategies were prompt response, early drives for vaccines, and effective awareness campaigns. Health Science Reports. 6(5). e1281–e1281. 14 indexed citations
14.
Sarker, Rapty, et al.. (2023). Risk Evaluation and Mitigation Strategies for Potential Outbreaks of Adenovirus Infection: Evidence From the Recent Incidences in West Bengal, India. SHILAP Revista de lepidopterología. 16. 2632010X231205672–2632010X231205672. 3 indexed citations
15.
Roknuzzaman, A. S. M., et al.. (2023). The possibility and challenge evaluation about the declaration of end of the pandemic phase of Covid-19. Annals of Medicine and Surgery. 85(5). 2237–2239. 5 indexed citations
16.
Sarker, Rapty, et al.. (2023). Benefits and probable ill effects of WHO’s declaration of end of COVID-19 pandemic: a way back to pandemic-free normal life. Annals of Medicine and Surgery. 85(6). 3199–3201. 8 indexed citations
17.
Rahman, Fahad Imtiaz, et al.. (2021). Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study. Infectious Disease Reports. 13(4). 888–901. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. S. M. Roknuzzaman Breakdown of academic impact, for papers by Henry Kyobe Bosa Breakdown of academic impact, for papers by Ami Fukunaga Breakdown of academic impact, for papers by Mosharop Hossian Breakdown of academic impact, for papers by Isobel Ward Breakdown of academic impact, for papers by Sarah Simmons Breakdown of academic impact, for papers by Sami Abdeen Breakdown of academic impact, for papers by Susana Rojas Breakdown of academic impact, for papers by Susy Rojas Breakdown of academic impact, for papers by Valerie Tulier-Laiwa
Rankless by CCL
2026